See All Slides - tctmd.com

Slides

Presentation TCT 2012

Top 5 Tips to Make CAS Safer

Presenter: Klaus Mathias

October 22, 2012

Presentation TCT 2012

Is Innovation in the United States on the Road to Recovery? An Interim Analysis and Critique

Presenter: Elazer Edelman

October 22, 2012

Presentation TCT 2012

Stroke After PCI vs. CABG (All Patients and Left Main Disease)

Presenter: Tullio Palmerini

October 22, 2012

Presentation TCT 2012

Industry-Sponsored vs. Investigator-Initiated Research: Similarities, Differences, and Pathways to Success

Presenter: David Kandzari

October 22, 2012

Presentation TCT 2012

What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents?

Presenter: Mark Wholey

October 22, 2012

Presentation TCT 2012

Randomized Trials Don't Reflect the Real World: Two Stents Should Be Used 50% of Bifurcation Lesions or More!

Presenter: Antonio Colombo

October 22, 2012

Presentation TCT 2012

Calcified Lesions: New Insights in Stable CAD and ACS from Large-Scale Clinical Trials

Presenter: Philippe Genereux

October 22, 2012

Presentation TCT 2012

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Presenter: Dimitri Karmpaliotis

October 22, 2012

Presentation TCT 2012

The Importance of Central Venous Occlusion, Techniques for Intervention, and Long-term Expectation of Outcomes

Presenter: Michael Dake

October 22, 2012

Presentation TCT 2012

Introduction(14)

Presenter: Sigmund Silber

October 22, 2012

Advertisement

Slides

Top 5 Tips to Make CAS Safer

Is Innovation in the United States on the Road to Recovery? An Interim Analysis and Critique

Stroke After PCI vs. CABG (All Patients and Left Main Disease)

Industry-Sponsored vs. Investigator-Initiated Research: Similarities, Differences, and Pathways to Success

What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents?

Randomized Trials Don't Reflect the Real World: Two Stents Should Be Used 50% of Bifurcation Lesions or More!

Calcified Lesions: New Insights in Stable CAD and ACS from Large-Scale Clinical Trials

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

The Importance of Central Venous Occlusion, Techniques for Intervention, and Long-term Expectation of Outcomes

Introduction(14)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content